The purpose of our study was to characterize the expression of p85 and p110 α subunits of Class IA PI3K in two large independents cohorts of NSCLC specimens and to assess the association with clinical and pathological variables including previously published mTOR expression. This evidence concerns the gene MTOR and non-small cell lung carcinoma.